Mesenchymal stem cell therapy in atherosclerosis: A bibliometric and visual analysis

Xing Cheng1, Ya-Ling Li1, Heng Wang1,2

  • 1Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.

World Journal of Stem Cells
|December 30, 2024
PubMed
Summary

This bibliometric analysis of mesenchymal stem cell (MSC) therapy for atherosclerosis (AS) reveals key research trends and future directions. It highlights leading countries, influential authors, and emerging topics like extracellular vesicles for advancing AS treatment.